@EYECANTFAIL Do you use 0,5-2% of you portfolio value or of you buying power (including margin) per trade?
English
vec
3K posts
Not sure of my win rate but it’s probably around 30%ish or lower, I just add super fucking aggressively to my winners and my losers are cut short, I lose like 0.5%-1% on 60-75% of my trades and make like 5% to even upwards of 20% on my big winners. I use a lot of leverage so I plan to size down once I have a good base portfolio amount to trade with.
But this has led me to be up now over 200% YTD.
I just make sure my winners are really fucking juicy and my losers are really fucking dry.
LuxAlgo@LuxAlgo
Most traders think they need to hit it out of the park every trade, but this is NOT the case. Mayne here explains how a <50% win rate can still be profitable by trading with positive skew. How to prompt AI for these high risk:reward strategies (🧵) x.com/Tradermayne/st…
English
The market doesn’t get the crypto and deep tech crossover that really kicked in this yr. Forced deleveraging in one bleeds straight into the other.
English
R.I.P McKinsey.
You can now use Perplexity AI to automate market research, competitive analysis, and strategy design for free.
Here’s the mega prompt you can steal ↓
(Comment "Send" and I'll DM you the mega prompts you can use for research)
English
🚨 Heisenberg Contest 🚨
Let's run another contest back. And I'll make it easier this time and guarantee the winner.
Guess $NVDA's exact closing price to end 2025. So the exact CLOSE on December 31st 2025.
Closest to it will win about $1,000 (judging from my recent X payouts). If tied, split between the ties.
I'll participate in it too. My guess is $230.69.
YOUR TURN!
#timestamped
English
English
I'm not a lawyer but 38% of their revenue last quarter was from semaglutide
And I am hearing $NVO is going to sue them. Will give more details later but @AndrewDudum brought this on while selling selling selling.
Can't wait for discovery, will be better than Johnny Depp v. Amber Heard
DoctorDueDiligence@DueDoctor
$HIMS-LOCK May 2024, Hims started Compounding Semaglutide, and was forced to stop, minus "personalized doses" until May 2025. How much did this affect Compounded Quarterly Growth Rate (CQGR)? Now you understand why their CEO is selling, why they wouldn't admit the amount, and why they are trying to skirt IP laws (RIP $NVO). There's a huge drop-off, so in order to lessen it, they want to continue to compound semaglutide. I think this opens up additional risk (mainly crackdown by FDA and/or $NVO lawsuit and potentially risk for MD providers).
English
@der_boss5 @yozgataner In physik sind 7 Leute du holst da so easy viele Punkte
Deutsch
@Vectoor53 @Drago46_ Damit die Girls dann endlich mal gleich alt sind hahah
Deutsch
